In this podcast, we discuss a new potential treatment for Parkinson's Disease has been developed by Bluerock Therapeutics that has completed and released results for the Phase 1 clinical trials. Involved in this research we have Dr. Claire Henchcliffe, MD, DPhil -Chair of Neurology at UC Irvine School of Medicine.
0:00- Introduction
1:54- What is this new potential treatment for Parkinsons’s Disease called and what is it?
3:31- Phase 1 clinical trial results
5:40- What kind of observations did your team make in terms of improvement of symptoms?
8:28- how is this treatment administered?
9:53- how often would this treatment be administered?
10:30- what would Phase 2 clinical trials look like?
10:40- how will success be measured for Phase 2?
13:30- how soon could this treatment be made widely available?
14:03- for what other diseases could this treatment potentially be used for?
16:08- final thoughts
#parkinson #parkinsonsdisease #stemcelltreatment
